Search research articles
Contact Us
Filters
Showing results (111-120 of 320) with videos related to
Page
of 32
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2011
The Japanese tsunami and resulting nuclear emergency at the Fukushima Daiichi power facility: technical, radiologic, and response perspectives
Lawrence T Dauer, Pat Zanzonico, R Michael Tuttle, et al.
Thyroid : Official Journal of the American Thyroid Association
|
July 26, 2012
Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans
Mona M Sabra, Ravinder K Grewal, Hernan Tala, et al.
Endocrine
|
November 2, 2020
Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient country
Friederike Eilsberger, R Michael Tuttle, Damiano Librizzi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 11, 2002
Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?
Richard J Robbins, Jajin Thomas Chon, Martin Fleisher, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
May 8, 2020
Assessing the Number of Candidates There Are for Active Surveillance of Low-risk Papillary Thyroid Cancers in the US
Benjamin R Roman, Piyush Gupta, R Michael Tuttle, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2004
Enzyme expression profiles suggest the novel tumor-activated fluoropyrimidine carbamate capecitabine (Xeloda) might be effective against papillary thyroid cancers of children and young adults
Aneeta Patel, Thomas Pluim, Amy Helms, et al.
Cancer
|
March 25, 2011
Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy
N Gopalakrishna Iyer, Luc G T Morris, R Michael Tuttle, et al.
Annals of Surgical Oncology
|
July 2, 2009
Micromedullary thyroid cancer: how micro is truly micro?
Venu G Pillarisetty, Steven C Katz, Ronald A Ghossein, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 5, 2009
Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern)
Michael Rivera, R Michael Tuttle, Snehal Patel, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 16, 2010
Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival
Luc G T Morris, Ashok R Shaha, R Michael Tuttle, et al.
Page
of 32
Search research articles
Search
Showing results (111-120 of 320) with videos related to
Sort By:
Page
of 32
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2011
The Japanese tsunami and resulting nuclear emergency at the Fukushima Daiichi power facility: technical, radiologic, and response perspectives
Lawrence T Dauer, Pat Zanzonico, R Michael Tuttle, et al.
Thyroid : Official Journal of the American Thyroid Association
|
July 26, 2012
Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans
Mona M Sabra, Ravinder K Grewal, Hernan Tala, et al.
Endocrine
|
November 2, 2020
Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient country
Friederike Eilsberger, R Michael Tuttle, Damiano Librizzi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 11, 2002
Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?
Richard J Robbins, Jajin Thomas Chon, Martin Fleisher, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
May 8, 2020
Assessing the Number of Candidates There Are for Active Surveillance of Low-risk Papillary Thyroid Cancers in the US
Benjamin R Roman, Piyush Gupta, R Michael Tuttle, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2004
Enzyme expression profiles suggest the novel tumor-activated fluoropyrimidine carbamate capecitabine (Xeloda) might be effective against papillary thyroid cancers of children and young adults
Aneeta Patel, Thomas Pluim, Amy Helms, et al.
Cancer
|
March 25, 2011
Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy
N Gopalakrishna Iyer, Luc G T Morris, R Michael Tuttle, et al.
Annals of Surgical Oncology
|
July 2, 2009
Micromedullary thyroid cancer: how micro is truly micro?
Venu G Pillarisetty, Steven C Katz, Ronald A Ghossein, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 5, 2009
Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern)
Michael Rivera, R Michael Tuttle, Snehal Patel, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 16, 2010
Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival
Luc G T Morris, Ashok R Shaha, R Michael Tuttle, et al.
Page
of 32